Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Accelerate Diagnostics News

    0,9215 $ -3,00% -0,0285 $
    In : 0,8626 € | 15:30:00 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3ENW4
    ISIN: US00430H2013
    US-Symbol: AXDX
    Typ: Aktie

    Accelerate Diagnostics News

    28.03.24 - PR Newswire
    Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
    Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results PR Newswire
    07.03.24 - PR Newswire
    Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
    Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. PR Newswire
    19.01.24 - PR Newswire
    Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
    Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement PR Newswire
    16.01.24 - PR Newswire
    Accelerate Diagnostics Announces Launch of Proposed Public Offering
    Accelerate Diagnostics Announces Launch of Proposed Public Offering PR Newswire
    07.01.24 - PR Newswire
    Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
    Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results PR Newswire
    27.11.23 - PR Newswire
    Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
    Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® PR Newswire
    09.11.23 - PR Newswire
    Accelerate Diagnostics Reports Third Quarter 2023 Results
    Accelerate Diagnostics Reports Third Quarter 2023 Results PR Newswire
    30.10.23 - PR Newswire
    Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
    Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results. PR Newswire
    10.08.23 - PR Newswire
    Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
    Accelerate Diagnostics Reports Second Quarter 2023 Financial Results PR Newswire
    27.07.23 - PR Newswire
    Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results
    Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results PR Newswire
    10.07.23 - PR Newswire
    Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split
    Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split PR Newswire
    13.06.23 - PR Newswire
    Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave
    Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-​Generation Platform Wave PR Newswire
    27.04.23 - PR Newswire
    Accelerate Diagnostics scheduled call to review 2023 first quarter results
    Accelerate Diagnostics scheduled call to review 2023 first quarter results PR Newswire
    29.03.23 - PR Newswire
    Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
    Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire
    15.03.23 - PR Newswire
    Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results
    Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results PR Newswire
    14.03.23 - PR Newswire
    Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement
    Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement PR Newswire
    08.03.23 - PR Newswire
    Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors
    Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors PR Newswire
    14.11.22 - PR Newswire
    Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
    Accelerate Diagnostics Reports Third Quarter 2022 Financial Results PR Newswire
    14.11.22 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX PR Newswire
    26.10.22 - PR Newswire
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation - AXDX
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation - AXDX PR Newswire

    Newssuche

    Videos

    newspaper
    08:50 Uhr
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »